CRIXIVAN
- Product NDC
- 0006-0571
- 11-digit product format
- 000060571
- Labeler code
- 0006
- Product ID
- 0006-0571_2f1ee2da-8e76-4c4e-8006-285449f74f1b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- indinavir sulfate
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Merck Sharp & Dohme Corp.
- Application
- NDA020685
- Marketing category
- NDA
- Marketing start
- 1996-03-13
- Marketing end
- 0000-00-00
- Substance
- INDINAVIR SULFATE
- Active strength
- 200 mg/1
- Pharmacologic classes
- HIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],Cytochrome P450 3A4 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0006-0571-43 | 00006057143 | 360 CAPSULE in 1 BOTTLE (0006-0571-43) | 360 capsule | 1996-03-13 | 0000-00-00 | No | No | Current |